Your browser doesn't support javascript.
loading
T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors.
Yamauchi, Takayoshi; Hoki, Toshifumi; Oba, Takaaki; Jain, Vaibhav; Chen, Hongbin; Attwood, Kristopher; Battaglia, Sebastiano; George, Saby; Chatta, Gurkamal; Puzanov, Igor; Morrison, Carl; Odunsi, Kunle; Segal, Brahm H; Dy, Grace K; Ernstoff, Marc S; Ito, Fumito.
Afiliação
  • Yamauchi T; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Hoki T; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Oba T; Merck Sharp & Dohme, Tokyo, Japan.
  • Jain V; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Chen H; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Attwood K; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Battaglia S; Department of Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, The State University of New York, Buffalo, NY, USA.
  • George S; Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Chatta G; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Puzanov I; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Morrison C; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Odunsi K; Department of Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, The State University of New York, Buffalo, NY, USA.
  • Segal BH; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Dy GK; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Ernstoff MS; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Ito F; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Nat Commun ; 12(1): 1402, 2021 03 03.
Article em En | MEDLINE | ID: mdl-33658501
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Biomarcadores Farmacológicos / Receptor 1 de Quimiocina CX3C / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Biomarcadores Farmacológicos / Receptor 1 de Quimiocina CX3C / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article